Texas Register, Volume 32, Number 23, Pages 3077-3422, June 8, 2007 Page: 3,154
3077-3422 p. ; 28 cm.View a full description of this periodical.
Extracted Text
The following text was automatically extracted from the image on this page using optical character recognition software:
of sodium iodide I131 for procedures requiring a written directive. The
training and experience shall include the following.
(A) Classroom and laboratory training shall include the
following:
(i) radiation physics and instrumentation;
(ii) radiation protection;
(iii) mathematics pertaining to the use and measure-
ment of radioactivity;
(iv) chemistry of radioactive material for medical
use; and
(v) radiation biology.
(B) Work experience, under the supervision of an au-
thorized user who meets the requirements of this subsection, subsection
(nn) or subsection (pp) of this section. A supervising authorized user
who meets the requirements in subsection (nn)(2) of this section, shall
also have experience in administering dosages as specified in subsec-
tion (nn)(2)(B)(vi)(I) or (II) of this section. The work experience shall
involve the following:
(i) ordering, receiving, and unpacking radioactive
materials safely and performing the related radiation surveys;
(ii) performing quality control procedures on instru-
ments used to determine the activity of dosages and performing checks
for proper operation of survey meters;
(iii) calculating, measuring, and safely preparing pa-
tient or human research subject dosages;
(iv) using administrative controls to prevent a med-
ical event involving the use of unsealed radioactive material;
(v) using procedures to contain spilled radioactive
material safely and using proper decontamination procedures; and
(vi) administering dosages of radioactive drugs to
patients or human research subjects that includes at least three cases
involving the oral administration of less than or equal to 33mCi (1.22
GBq) of sodium iodide I-131; and
(4) has obtained written attestation that the individual has
satisfactorily completed the requirements of paragraph (3) of this sec-
tion, and has achieved a level of competency sufficient to function in-
dependently as an authorized user for the medical uses authorized in
accordance with subsection (kk) of this section. The written attesta-
tion shall be signed by a preceptor authorized user who meets the re-
quirements of this subsection, subsection (nn) or subsection (pp) of this
section. A preceptor authorized user, who meets the requirements in
subsection (nn)(2) of this section shall also have experience in admin-
istering dosages as specified in subsection (nn)(2)(B)(vi)(I) or (II) of
this section.
(pp) Training for the oral administration of sodium iodide
1-131 requiring a written directive in quantities greater than 33 mCi
(1.22 GBq). Except as provided in subsection (1) of this section, the
licensee shall require an authorized user for the oral administration of
sodium iodide I-131 requiring a written directive in quantities greater
than 33 mCi (1.22 GBq) to be a physician who:
(1) is certified by a medical specialty board whose certifi-
cation process includes all of the requirements in paragraph (3) of this
subsection and whose certification has been recognized by the agency,
the NRC, an agreement state, or licensing state and who meets the re-
quirements of paragraph (4) of this subsection). (The names of board
certifications which have been recognized by the agency, the NRC,agreement state or licensing state will be posted on the agency's web
page, www.dshs.state.tx.us/radiation);
(2) is an authorized user in accordance with subsection (nn)
of this section for uses listed in subsection (nn)(2)(B)(vi)(II) of this
section; or
(3) has training and experience including, having success-
fully completed 80 hours of classroom and laboratory training applica-
ble to the medical use of sodium iodide I-131 for procedures requiring
a written directive. The training and experience shall include the fol-
lowing.following:
(A) Classroom and laboratory training shall include the
(i) radiation physics and instrumentation;
(ii) radiation protection;
(iii) mathematics pertaining to the use and measure-ment of radioactivity;
(iv) chemistry of radioactive material for medical
use;
(v) radiation biology.
(B) Work experience, under the supervision of an au-
thorized user who meets the requirements of subsection (nn) or (pp)
of this section. A supervising authorized user who meets the require-
ments of subsection (nn)(2) of this section, shall also have experience
in administering dosages as specified in subsection (nn)(2)(B)(vi)(II)
of this section. The work experience shall involve the following:
(i) ordering, receiving, and unpacking radioactive
materials safely and performing the related radiation surveys;
(ii) performing quality control procedures on instru-
ments used to determine the activity of dosages and performing checks
for proper operation of survey meters;
(iii) calculating, measuring, and safely preparing pa-
tient or human research subject dosages;
(iv) using administrative controls to prevent a med-
ical event involving the use of unsealed radioactive material;
(v) using procedures to contain spilled radioactive
material safely and using proper decontamination procedures; and
(vi) administering dosages of radioactive drugs to
patients or human research subjects that includes at least three cases
involving the oral administration of greater than 33mCi (1.22 GBq) of
sodium iodide I-131; and
(4) has obtained written attestation that the individual has
satisfactorily completed the requirements of paragraph (3) of this sub-
section, and has achieved a level of competency sufficient to function
independently as an authorized user for the medical uses authorized in
accordance with subsection (kk) of this section. The written attestation
shall be signed by a preceptor authorized user who meets the require-
ments in this subsection or subsection (nn) of this section. The precep-
tor authorized user, who meets the requirements in subsection (nn)(2)
of this section, shall also have experience in administering dosages as
specified in subsection (nn)(2)(B)(vi)(II) of this section.
(qq) Training for the parenteral administration of unsealed ra-
dioactive material requiring a written directive. Except as provided in
subsection (1) of this section, the licensee shall require an authorized
user for the parenteral administration requiring a written directive to
be a physician who:32 TexReg 3154 June 8, 2007 Texas Register
Upcoming Pages
Here’s what’s next.
Search Inside
This issue can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Periodical.
Texas. Secretary of State. Texas Register, Volume 32, Number 23, Pages 3077-3422, June 8, 2007, periodical, June 8, 2007; Austin, Texas. (https://texashistory.unt.edu/ark:/67531/metapth97400/m1/77/: accessed July 16, 2024), University of North Texas Libraries, The Portal to Texas History, https://texashistory.unt.edu; crediting UNT Libraries Government Documents Department.